Brief: Anthera Pharmaceuticals reports third quarter loss per shr of $0.61

Anthera Pharmaceuticals

04/11/2016 12:38

Nov 4 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O : 
    * Anthera pharmaceuticals provides business update and 
reports 2016 third quarter financial results 
    * Qtrly loss per share $0.61  
    * Expect to report topline efficacy data from solution study 
before end of 2016 
 
Source text for Eikon:  ID:nGNXNKPEZa  
Further company coverage:  ANTH.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))